PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 40.12
+1.27 (3.27%)
Jul 14, 2026, 4:00 PM EDT
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 5.52 billion as of July 14, 2026. Its market cap has increased by 20.16% in one year.
Market Cap
5.52B
Enterprise Value
5.39B
Revenue
691.21M
Ranking
n/a
PE Ratio
125.85
Stock Price
40.12
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 5.52B, an increase of 40.12%. That is a compound annual growth rate of 9.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 5.52B | 34.32% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghua Biological Products | 6.05B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.05B |
| Youcare Pharmaceutical Group | 6.04B |
| Wuhan Keqian Biology Co.,Ltd | 5.97B |
| Beijing Konruns Pharmaceutical | 5.66B |
| Novogene | 5.35B |
| Hangzhou Biotest Biotech | 5.29B |
| R&G PharmaStudies | 5.09B |